NRIX (Nurix Therapeutics Inc) Earnings per share for the last four quarters

Public company logo of Nurix Therapeutics Inc (NRIX)

Nurix Therapeutics (NRIX) is establishing a cutting-edge targeted protein degradation environment to combat oncology. The annual EPS (TTM) change reflects the dynamics of this process, while the 184.90 value indicates the yield status. Development relies on extensive outsourcing of late-stage testing, with the overall system's stability directly dependent on strict FDA safety regulations.

NRIX nurixtx.com Earnings per share for the last twelve months (02/11/2024 - 11/18/2026)

Nurix Therapeutics Inc - analytical breakdowns and key metrics (NRIX)

- current price and projected stock value:
- business market valuation indicators:
Fundamental valuation:Nurix Therapeutics, Inc. (NRIX)
Signature product of Nurix Therapeutics, Inc.

This indicator measures the rate of change in earnings per share over a rolling twelve-month period, allowing for an assessment of value generation efficiency relative to the market price. For Nurix Therapeutics (NRIX), the EPS YoY TTM percentage trend reflects the business's resilience to geopolitical risks within component supply chains and patent disputes, revealing the company's actual strength relative to the sector.

Competitor analysis for Nurix Therapeutics

Earnings per share for the trailing year GMAB (Genmab US)|EXEL (Exelixis) - Net earnings per share for the last 12 months|NUVL: Earnings per share for the last four quarters|KYMR (Kymera Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ideayabio.com|Earnings per share for the last twelve months Enliven Therapeutics, Inc. (ELVN)|ORIC (ORIC Pharmaceuticals, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RLAY (Relay Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|CCCC (c4therapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Black Diamond Therapeutics Inc. BDTX|Net earnings per share (EPS TTM) RPTX|PMV Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Karyopharm Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year PPCB|BGMS: Net earnings per share for the last 12 months|aadibio.com - Earnings per share for the last four quarters|ALRN: Net earnings per share (EPS TTM)|Blueprint Medicines Corp. - Earnings per share for the trailing year|GLYC (GlycoMimetics Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months SpringWorks Therapeutics Inc. SWTX